The Doctors Company Acquisition Information Center
ProAssurance Group is pleased to announce that ProAssurance has agreed to be acquired by The Doctors Company. Upon close, this transaction will solidify the combined organization as the second largest medical malpractice insurance company in the country and the largest physician-owned carrier. This page will be kept updated with the most current information. Shareholders with questions should contact our head of Investor Relations, Heather Wietzel, at InvestorRelations@ProAssurance.com or 205-776-3028.
Other information can be found in our filings with the SEC.
Disclaimer
This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that represent the current expectations and beliefs of management of ProAssurance Corporation (“ProAssurance”) concerning the proposed acquisition of ProAssurance Corporation by The Doctors Company (“Buyer”) and other future events and their potential effects on ProAssurance. Such statements are based upon the current beliefs and expectations of ProAssurance management, are not guarantees of future results and are subject to a significant number of risks and uncertainties. These forward-looking statements are inherently subject to significant business, economic and competitive uncertainties and contingencies and risk relating to the transaction, many of which are beyond ProAssurance’s control.
In connection with the proposed acquisition, ProAssurance has mailed the definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on May 14, 2025 to its stockholders. INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT PROASSURANCE AND BUYER, THE PROPOSED ACQUISITION AND RELATED MATTERS. Investors and stockholders may obtain free copies of the proxy statement and other documents filed with the SEC by ProAssurance through the website maintained by the SEC at http://www.sec.gov. In addition, investors and stockholders may obtain free copies of the definitive proxy statement and other documents filed by ProAssurance with the SEC upon written request to: Investor Relations, ProAssurance Corporation, P.O. Box 590009, Birmingham, Alabama 35259-0009 or by telephone at (205) 776-3028 or (800) 282-6242. Information regarding the persons who may, under the rules of the SEC, be considered participants in the solicitation of proxies from ProAssurance’s stockholders in connection with the proposed acquisition is set forth in ProAssurance’s proxy statement for its 2025 annual meeting of stockholders, which was filed with the SEC on April 11, 2025. Additional information regarding the interests of ProAssurance’s directors and executive officers in the proposed acquisition, which may be different than those of ProAssurance’s stockholders generally, is contained in the proxy statement.